Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...

Problematic software has been the cause of multiple infusion pump recalls in the medical device industry over the past few years.

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Keta (VR), March 14, GNA – In a significant crackdown on illicit drug smuggling, the Keta Divisional Police Command in the ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has urged Nigerians to start using its latest app, known as the Greenbook, which is capable of verifying and detecting fake ...

With ketamine removed from the FDA drug shortage list, the FDA is expected to restrict ... solicitation or sale would be unlawful prior to registration or qualification under the securities laws of ...

Hims & Hers has bet big on prescribing compounded versions of these drugs, including by buying its own compounding pharmacy in September. The FDA has allowed pharmacies to make compounded versions ...

Generic names are assigned by international organizations, such as the U.S. Adopted Names (USAN) Council, the Food and Drug Administration (FDA), or the World Health Organization (WHO), to ensure ...